AI-Based Medical Data Analysis Solution Service

FRONTEO Healthcare’s new AI (artificial intelligence) is built upon the healthcare industry’s most fundamental requirement—evidence-based medicine. Through our data analysis capability, we hope to support people around the world in receiving the best healthcare services and pave the way to a healthier, more secure future.

Diagnosis Support

Our AI-based technology reads written entries from examination records and brings a new objectivity to the evaluation of new drugs. By combining this technology with conventional quantitative/structured data analysis, it is possible to make the evaluation of pharmaceuticals even more precise. Using our sophisticated AI technology, we will find new value in pharmaceuticals, as well as support all healthcare workers.

Healthcare Operational Support

Case: An AI-based system to mitigate patients’ risk of falling

FRONTEO Healthcare's AI can be used to analyze hospital incident reports, including data on patient conditions from electronic folders as well as the text data of free comments found in daily records of examination and treatment. This allows the AI to calculate the risk of falls faced by the hospital's patients. Based on projections regarding accidents involving falls and a variety of other potential risks internal to healthcare institutions, we are able to detect symptoms that are signs of adverse events—a task that was previously left to the experience and intuition of nurses in the workplace—from electronic medical records in an accurate, rapid, and continuous fashion. In this way, FRONTEO Healthcare's AI can identify those patients who are at a high risk of falling and thus especially in need of nursing care, contribute to reducing unexpected adverse events, and provide reliable support for the work of medical staff.
Introducing a system for appropriately evaluating and sharing the collective expertise of healthcare workers will create better hospital environments, and increasing the time of interaction between nurses and patients will facilitate greater focus, as should be the case, on the care of each patient.

Pharmaceutical Industry Support

With the globalization of the pharmaceutical industry, pharmacovigilance continues to grow in importance. While accurate and prompt responses are required for pharmacovigilance, the processing of text data, which includes reports filed in a variety of formats, has proved time-consuming in practice, and there have been many instances where important elements were overlooked. FRONTEO Healthcare's AI enables the resolution of such issues faced in clinical practice through the analysis of text data. With the aim of making pharmacovigilance work significantly more efficient and of higher quality, we will contribute toward the management of safety information for pharmaceuticals.

A new challenge: Using AI to tackle big data in healthcare Drawing on and using experts' tacit knowledge

Learn More

Profile

Company name FRONTEO Healthcare, Inc.
Date of foundation April 16, 2015
Capital amount JPY 327,000 thousand (On the date of February 1, 2017)
Senior management
  • Executive Chairman: Masahiro Morimoto
  • Chief Executive Officer: Kuniko Nishikawa
  • Director: Naritomo Ikeue
  • Director: Hideki Takeda
  • Director: Takuji Kurio
  • Auditor: Tomohiro Uesugi
Business contents
  • Diagnosis support
  • Healthcare operational support
  • Pharmaceutical industry support
  • Other healthcare-related information analysis businesses
Location Meisan Takahama building, 2-12-23, Konan, Minato-ku, Tokyo 108-0075
Phone: +81-3-5463-6330

Contact Us

Please refer to the contact form below.

Contact Form